Metabolic parameters after BloEnterics Intragastric Balloon placement in obese patients

Journal of Endocrinological Investigation

Volumn 32, Issue 2, 2009, Pages 165-168

  Donadio, F ^a   Sburlati, L F ^a   Masserini, B ^a   Lunati, E M ^a   Lattuada, E ^b   Zappa, M A ^b   Mozzi, E ^b   Beck Peccoz, P ^a   Orsi, E ^a  

^a Endocrinology and Diabetes Unit   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

BIB ; Cardiovascular risk; Fat mass; Fat free mass; Insulin resistance; Nutritional habits; Obesity; Weight loss

Indexed keywords

CARBOHYDRATE; LIPID;

ADULT; ANTHROPOMETRY; ARTICLE; BALLOON; BODY MASS; CALORIC INTAKE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FAT INTAKE; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC PARAMETERS; NUTRITIONAL PARAMETERS; OBESITY; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; LIPID METABOLISM; METABOLISM; MIDDLE AGED; MORBID OBESITY; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; ENERGY INTAKE; FEMALE; FOOD HABITS; GASTRIC BALLOON; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; OBESITY, MORBID; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 67649410707     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345708     Document Type: Article

References (37)

1. Jung RT. Obesity as a disease. Br Med Bull 1997, 53: 307-21.
2. Haslam DW, James WPT. Obesity. Lancet 2005, 366: 1197-209.
3. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of person 50 to 71 years old. N Engl J Med 2006, 355: 763-78.
4. Banegas JR, López-Garcia E, Gutiérrez-Fisac JL, Guallar-Castillón P, Rodríguez-Artalejo F. A simple estimate of mortality attributable to excess weight in the European Union. Eur J Clin Nutr 2003, 57: 201-8.
5. Jones LR, Wilson CI, Wadden TA. Lifestyle modification in the treatment of obesity: an educational challange and opportunity. Clin Pharm Ther 2007, 81: 776-9.
6. Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346: 393-403.
7. World Health Organization C4IHO): A guide for population-based approach to increasing levels of physical activity. WHO Publication 2007; www.who.int/dietphysicalactivity/en/
8. Goldstein DJ. Beneficial health effects of modest weight loss. lnt J Obes Relat Metab Disord 1992, 16: 397-41 5.
9. Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated rneta-analysis. BMJ 2007, 335: 1194-9.
10. Fried M, Hainer V, Basdevant A, et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes 2007, 31: 569-77.
11. Doldi SB, Micheletto G, Di Prisco F, et al. Intragastric balloon in obese patients. Obes Surg 2000, 10: 578-81.
12. Doldi SB, Micheletto G, Perrini MN, Librenti MC, Rella S. Treatment of morbid obesity with intragastric balloon in association with diet. Obes Surg 2002, 12: 583-7.
13. Genco A, Bruni T, Doldi SB, et al. BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients. Obes Surg 2005, 15: 1161-4.
14. Al-Momen A, El-Mogy I. Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg 2005, 15: 101-5.
15. Fernandes M, Atallah AN, Soares EG, et al. lntragastric balloon for obesity. Cochrane Database Syst Rev 2007, CD004931.
16. Hubbard VS, Hall WH. Gastrointestinal surgery for severe obesity. Obes Surg 1991,1:257-65.
17. Frisard MI, Greenway FL, Delany JP. Comparison of methods to assess body composition changes during a period of weight loss. Obes Res 2005, 13: 845-54.
18. Kushner RF, Kunigk A, Alspaugh M, Andronis PT, Leitch CA, Schoeller DA. Validation of bioelectrical-impedance analysis as a measurement of change in body composition in obesity. Am J Clin Nutr 1990, 52: 21 9-23.
19. Chouinard LE, Schoeller DA, Watras AC, Clark RR, Close RN, Buchholz AC. Bioelectrical impedance vs. four-compartment model to assess body fat change in overweight adults. Obesity (Silver Spring) 2007, 15: 85-92.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Horneostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412-9.
21. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health. Obes Res 1998,6 (Suppl. 2): 51S-209S.
22. Benjamin SB, Maher KA, Cattau EL, etal. Double-blind controlled trial of the Garren-Edward gastric bubble: an adjurrctive treatment for exogenous obesity. Gastroenterology 1988, 95: 581-8.
23. Mathus-Vliegen EM, Tytgat GN. Intragastric balloons for morbid obesity: results, patient tolerance and balloon life span. Br J Surg 1990, 77: 77-9.
24. Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 2007, 27: 996-1003.
25. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444: 840-6.
26. Kriketos AD, Carey DG, Jenkins AB, Chishoirn DJ, Furler SM, Campbell LV. Central fat predicts deterioration of insulin secretion index and fasting glycaemia: 6-year follow-up of subjects at varying risk of Type 2 diabetes mellitus. Diabet Med 2003, 20:294-300.
27. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116: 39-48.
28. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998, 83: 2773-6.
29. D'Agostino RB Jr, Hamn,an RF, Karter AJ, Mykkanen L, Wagenknecht LE, Haffner SM; Insulin Resistance Atherosclerosis Study Investigators. Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care 2004, 27: 2234-40.
30. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24: 683-9.
31. Bonora E, Kiechl 5, Willeit J, et al; Bruneck study. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 2003, 26: 1251-7.
32. Bonora E, Kiechi S. WiIIeitJ, et al. Bruneck study. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 2004, 53: 1782-9.
33. Dixon JB, Strauss BJ, Laurie C, O'Brien PE. Changes in body composition with weight loss: obese subjects randomized to surgical and medical programs. Obesity (Silver Spring) 2007, 15: 1187-98.
34. Muscelli E, Mirigrone G, Camastra S, et al. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med 2005, 118: 51-7.
35. Vogels N, Westerterp-Plarrterrga MS. Successful long-term weight maintenance: a 2-year follow-up. Obesity (Silver Spring) 2007, 15: 1258-66.
36. Brownell KD, Rodin J. Medical, metabolic, and psychological effects of weight cycling. Arch mt Med 1994, 154: 1325-30.
37. Christiansen T, Bwun JM, Madsen EL, Richelsen B. Weight loss maintenance in severely obese adults after an intensive lifestyle intervention: 2-to 4-year follow-up. Obesity (Silver Spring) 2007, 15: 413-20.